N10 Wealth »

Royalty Pharma shares owned by N10 Wealth

Quarter-by-quarter ownership of Royalty Pharma (RPRX) shares owned by N10 Wealth from 13F filings

Historical chart of N10 Wealth investment in Royalty Pharma

Tip: Access up to 7 years of quarterly data

All positions including Royalty Pharma held by N10 Wealth consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Royalty Pharma by N10 Wealth

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.7M 30k 56.07

More positions owned by N10 Wealth

Angel Oak Funds Trust Income Etf (CARY)
Vertiv Holdings Com Cl A (VRT)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl C (GOOG)
Amazon (AMZN)
Lam Research Corp Com New (LRCX)
Alphabet Cap Stk Cl A (GOOGL)
Sandisk Corp (SNDK)
Marvell Technology (MRVL)
Ge Vernova (GEV)
Meta Platforms Cl A (META)
Broadcom (AVGO)
Axon Enterprise (AXON)
Quanta Services (PWR)

View all positions for N10 Wealth

Top funds holding Royalty Pharma

Morgan Stanley
Capital Research and Management Company - Division 3
BlackRock
FMR
Swedbank AB
State Street Corporation
Baillie Gifford & Co
Capital World Investors
Geode Capital Management
Adage Capital Partners GP
Caledonia
Vanguard Capital Management
Northern Trust
Royal London Asset Management
Legal & General Group

View all funds holding Royalty Pharma